Clover Health Investments, Corp. (CLOV) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Clover Health operates as a Medicare Advantage insurer utilizing its proprietary "Clover Assistant" technology platform to manage chronic diseases and lower costs. The company operates PPO and HMO plans across five states. As of June 30, 2025, the company reported 106,323 members, a significant increase from 80,261 members at the end of the prior year.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Total Revenues | $477.6 million | $356.3 million | $939.9 million | $703.2 million |
| Premiums Earned (Net) | $469.8 million | $349.9 million | $926.7 million | $691.6 million |
| Net Medical Claims Incurred | $378.0 million | $248.3 million | $731.4 million | $513.5 million |
| Net (Loss) Income | $(10.6) million | $7.4 million | $(11.9) million | $(11.8) million |
| Adjusted EBITDA (Non-GAAP) | $17.1 million | $36.2 million | $42.9 million | $43.0 million |
| Cash & Equivalents | $188.6 million | N/A | $188.6 million | $254.8 million |
| Total Investments | $188.0 million | N/A | $188.0 million | $243.1 million |
Liquidity & Debt: The company holds no material debt. Total cash, cash equivalents, and investments stood at $389.3 million as of June 30, 2025, down from $437.6 million at year-end 2024. The company reported a net operating cash outflow of $10.9 million for the six months ended June 30, 2025.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 34.1% year-over-year for Q2 2025, driven primarily by a 32% increase in average membership.
- Profitability Shift: The company reported a net loss of $10.6 million for Q2 2025, compared to a net income of $7.4 million in Q2 2024. This reversal was driven by a 52.2% increase in net medical claims incurred, which outpaced revenue growth.
- Medical Loss Ratio: The Benefits Expense Ratio (BER) increased to 88.4% in Q2 2025 from 76.1% in Q2 2024. Management attributed the increase in claims to membership growth and higher Part D cost sharing due to the Inflation Reduction Act.
- Operating Expenses: Salaries and benefits rose 10.5% and General and Administrative (G&A) expenses rose 9.1% year-over-year, largely due to headcount increases to support membership growth and higher broker fees.
- Stock Repurchases: The company repurchased $18.3 million of Class A Common Stock during the first six months of 2025.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted that the increase in medical claims was expected due to membership growth and regulatory changes (Inflation Reduction Act). They noted that claims processing speed improved, with the ratio of current year claims paid to incurred rising to 81.7% in the first half of 2025 from 67.6% in the prior year. The company continues to focus on its "Counterpart Health" SaaS offering to monetize its technology externally.
Risks and Contingencies:
- Regulatory Environment: The company faces risks related to CMS Risk Adjustment Data Validation (RADV) audits, which CMS announced intentions to significantly increase in May 2025.
- Legislation: The company is evaluating the impact of the "One Big Beautiful Bill Act" (OBBBA) signed into law on July 4, 2025, which enacts significant changes to the US federal corporate income tax system. The financial impact cannot yet be reasonably estimated.
- Legal Proceedings: The SEC concluded its investigation into the company in September 2024 without recommending enforcement action. A securities class action settlement was approved in October 2023, funded by insurance proceeds.
Investor Verification Checklist
- Medical Loss Ratio Trend: Verify if the 88.4% BER is a temporary anomaly due to the Inflation Reduction Act or a structural shift in underwriting profitability.
- Cash Burn Rate: Monitor the shift from positive operating cash flow in H1 2024 ($79.7M) to negative operating cash flow in H1 2025 ($10.9M) and its sustainability.
- Membership Quality: Assess the risk profile of the 32% membership growth to ensure new members are not disproportionately high-cost.
- Tax Legislation Impact: Review future filings for the quantified impact of the OBBBA on the company's deferred tax assets and effective tax rate.
- Counterpart Health Revenue: Determine if the external SaaS business (Counterpart Health) is generating material revenue to offset insurance margin compression.